GlassScriptPhysician profile
Wesley M Stuckey
NPI 1881621142
$1,832.18
in general payments reported to CMS, 2019-2025
33 companies · $566 in 2025
The $566 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $390 · 2020: $63.56 · 2021: $136 · 2022: $90.63 · 2023: $244 · 2024: $341 · 2025: $566.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,151.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $285.61 | 2024-2025 | Veozah |
| Abbvie INC. | $268.14 | 2019-2022 | |
| Coloplast Corp | $229.66 | 2019-2025 | Altis |
| Exeltis, USA INC. | $142.77 | 2023-2025 | Slynd |
| Biogen, INC. | $101.62 | 2025 | Zurzuvae |
| Intuitive Surgical, INC. | $86.21 | 2019 | |
| Sumitomo Pharma America, INC. | $64.50 | 2025 | Myfembree, Gemtesa |
| Therapeuticsmd, INC. | $63.55 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $52.55 | 2019-2025 | |
| Pfizer INC. | $48.48 | 2023-2024 | |
| Ethicon US, LLC | $46.22 | 2019-2024 | Evicel Fibrin Sealant (Human), Ethicon, Vistaseal |
| Boston Scientific Corporation | $37.82 | 2022-2025 | General - Female Sui |
| Merck Sharp & Dohme LLC | $36.81 | 2019-2020 | |
| Shield Therapeutics INC | $34.65 | 2024-2025 | |
| Mayne Pharma Commercial LLC | $34.58 | 2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $24.23 | 2021 | |
| Bausch Health US, LLC | $23.53 | 2022 | |
| Coopersurgical, INC. | $23.07 | 2019 | |
| Medtronic, INC. | $22.96 | 2022 | |
| Aspira Women'S Health INC | $21.71 | 2019-2024 | Ova1 |
| Novo Nordisk INC | $18.94 | 2023 | Wegovy |
| Lsi Solutions INC | $18.11 | 2024 | Fornisee |
| Organogenesis INC. | $16.51 | 2024 | |
| Axonics, INC. | $16.23 | 2024 | Bulkamid, Axonics |
| Ambu INC. | $15.56 | 2024 | |
| Linvatec Corporation | $15.41 | 2024 | Hall Power |
| Lilly USA, LLC | $15.29 | 2025 | Zepbound |
| Optumhealth Care Solutions, LLC | $15.21 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Molnlycke Health Care US, LLC | $14.16 | 2024 | Mepilex Border Post-Op Ag |
| Avion Pharmaceuticals | $13.20 | 2022 | |
| Solventum Corporation | $13.12 | 2024 | Prevena |
| Amag Pharmaceuticals, INC. | $11.77 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wesley Stuckey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.